Trial Profile
Effect of CTLA-4-Ig (abatacept) on human B lymphocyte function and specificity for citrullinated protein antigens in rheumatoid arthritis (RA) - Abatacept and B cells
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 04 Nov 2019 Status changed from recruiting to completed.
- 14 Dec 2017 New trial record